Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial
Titel:
Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial
Auteur:
Morris, Michael J. Loriot, Yohann Sweeney, Christopher J. Fizazi, Karim Ryan, Charles J. Shevrin, Daniel H. Antonarakis, Emmanuel S. Pandit-Taskar, Neeta Deandreis, Désirée Jacene, Heather A. Vesselle, Hubert Petrenciuc, Oana Lu, Cindy Carrasquillo, Jorge A. Higano, Celestia S.